Fleseriu M, Petersenn S, Biller BMK. et al. Long-term efficacy and safety of once-monthly pasireotide in Cushing’s disease: A Phase III extension study. Clin Endocrinol (Oxf). 2019; DOI: 10.1111/cen.14081.
Download Bibliographical Data
We do not assume any responsibility for the contents of the web pages of other providers.